NCT01653262View on ClinicalTrials.gov

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Epilepsy

Interventions

DRUG

Brivaracetam

Trial Locations (12)

Unknown

103, Little Rock

108, Lexington

109, New York

106, Akron

110, Dallas

102, Salt Lake City

203, Amiens

201, Paris

303, Bernau

300, Kehl-Kork

502, Seville

603, Salford

All Listed Sponsors

lead

UCB Pharma SA

INDUSTRY

NCT01653262 - Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) | Biotech Hunter | Biotech Hunter